User menu

A polyclonal anti-vaccine CD4 T cell response detected with HLA-DP4 multimers in a melanoma patient vaccinated with MAGE-3.DP4-peptide-pulsed dendritic cells

Bibliographic reference Zhang, Y. ; Renkvist, N ; Sun, ZJ ; Schuler-Thurner, B. ; Glaichenhaus, N ; et. al. A polyclonal anti-vaccine CD4 T cell response detected with HLA-DP4 multimers in a melanoma patient vaccinated with MAGE-3.DP4-peptide-pulsed dendritic cells. In: European Journal of Immunology, Vol. 35, no. 4, p. 1066-1075 (2005)
Permanent URL
  1. Coulie, Proc. Natl. Acad. Sci. USA, 98, 10290 (2001)
  2. Coulie, Immunol. Rev., 188, 33 (2002)
  3. Coulie, Curr. Opin. Immunol., 15, 131 (2003)
  4. Lonchay, Proc. Natl. Acad. Sci. USA, 101, 14631 (2004)
  5. Schuler-Thurner, J.?Exp. Med., 195, 1279 (2002)
  6. Phan, J.?Immunother., 26, 349 (2003)
  7. Altman, Science, 274, 94 (1996)
  8. Day, J.?Clin. Invest., 112, 831 (2003)
  9. Meyer, Proc. Natl. Acad. Sci. USA, 97, 11433 (2000)
  10. Danke N. A., Kwok W. W., HLA Class II-Restricted CD4+ T Cell Responses Directed Against Influenza Viral Antigens Postinfluenza Vaccination, 10.4049/jimmunol.171.6.3163
  11. Lucas, J.?Virol., 78, 7284 (2004)
  12. Ye, Hum. Immunol., 65, 507 (2004)
  13. Kwok W. W., Liu A. W., Novak E. J., Gebe J. A., Ettinger R. A., Nepom G. T., Reymond S. N., Koelle D. M., HLA-DQ Tetramers Identify Epitope-Specific T Cells in Peripheral Blood of Herpes Simplex Virus Type 2-Infected Individuals: Direct Detection of Immunodominant Antigen-Responsive Cells, 10.4049/jimmunol.164.8.4244
  14. Novak, J.?Clin. Invest., 104, r63 (1999)
  15. Lemaître, Eur. J. Immunol., 34, 2941 (2004)
  16. Schultz, Cancer Res., 60, 6272 (2000)
  17. Malherbe, Immunity, 13, 771 (2000)
  18. Reichstetter S., Ettinger R. A., Liu A. W., Gebe J. A., Nepom G. T., Kwok W. W., Distinct T Cell Interactions with HLA Class II Tetramers Characterize a Spectrum of TCR Affinities in the Human Antigen-Specific T Cell Response, 10.4049/jimmunol.165.12.6994
  19. Schultz E. S., Schuler-Thurner B., Stroobant V., Jenne L., Berger T. G., Thielemanns K., van der Bruggen P., Schuler G., Functional Analysis of Tumor-Specific Th Cell Responses Detected in Melanoma Patients after Dendritic Cell-Based Immunotherapy, 10.4049/jimmunol.172.2.1304
  20. Wang, Immunity, 20, 107 (2004)
  21. Godelaine D., Carrasco J., Lucas S., Karanikas V., Schuler-Thurner B., Coulie P. G., Schuler G., Boon T., Van Pel A., Polyclonal CTL Responses Observed in Melanoma Patients Vaccinated with Dendritic Cells Pulsed with a MAGE-3.A1 Peptide, 10.4049/jimmunol.171.9.4893
  22. Karanikas V., Lurquin C., Colau D., van Baren N., De Smet C., Lethe B., Connerotte T., Corbiere V., Demoitie M.-A., Lienard D., Dreno B., Velu T., Boon T., Coulie P. G., Monoclonal Anti-MAGE-3 CTL Responses in Melanoma Patients Displaying Tumor Regression after Vaccination with a Recombinant Canarypox Virus, 10.4049/jimmunol.171.9.4898
  23. Zhang Y., Chaux P., Stroobant V., Eggermont A. M. M., Corthals J., Maillere B., Thielemans K., Marchand M., Boon T., van der Bruggen P., A MAGE-3 Peptide Presented by HLA-DR1 to CD4+ T Cells That Were Isolated from a Melanoma Patient Vaccinated with a MAGE-3 Protein, 10.4049/jimmunol.171.1.219
  24. Thurner, J.?Exp. Med., 190, 1669 (1999)
  25. Schuler-Thurner B., Dieckmann D., Keikavoussi P., Bender A., Maczek C., Jonuleit H., Roder C., Haendle I., Leisgang W., Dunbar R., Cerundolo V., von den Driesch P., Knop J., Brocker E. B., Enk A., Kampgen E., Schuler G., Mage-3 and Influenza-Matrix Peptide-Specific Cytotoxic T Cells Are Inducible in Terminal Stage HLA-A2.1+ Melanoma Patients by Mature Monocyte-Derived Dendritic Cells, 10.4049/jimmunol.165.6.3492
  26. Scott, Protein Sci., 7, 413 (1998)
  27. Scott, J.?Exp. Med., 183, 2087 (1996)
  28. Bunch, Nucleic Acids Res., 16, 1043 (1988)
  29. Genevée, Eur. J. Immunol., 22, 1261 (1992)